Q1 2026 standalone results: Revenue 29.5B won (24.7% YoY increase from 23.6B), operating profit 4.0B won, net income 3.6B won (36.5% YoY increase from 2.7B)
Debt ratio at 18.28%, maintaining a healthy financial structure (up slightly from 14.74% at year-end 2025)
Declared cash dividend for FY2025 of 3.4B won (475 won per share), approved at AGM on 2026.03.26
Put option obligation for SK Chemical's 50% stake in JV (6.0B won, exercisable from 2025) and land repurchase right
Credit rating maintained at A (eCredit), R&D investment of 635M won (2.15% of revenue)